Novedades

• FDA approves generic teriparatide and levetiracetam
• US generics launch and approval for Dr Reddy’s and Lupin
• Five Chinese companies join UN’s MPP for Covid-19 medicines
• South Korean companies to make generic Bridion and COVID-19 drugs

Investigación

• Generic medications in the Lebanese community: understanding and public perception
• Community pharmacists’ understanding of generic and biosimilar drugs: Lebanon case study
• Reshaping landscape of Japanese generics market – uncertain future of universal health insurance
• Impact of e-bidding procurement on generic omeprazole injection prices in Thailand

General

• Crecimiento de medicamentos genéricos en Brasil y Venezuela
• Penetración de los medicamentos genéricos en México y Brasil
• FDA releases one-year progress report for the Generic Drug Cluster
• Empresas de fabricación de productos farmacéuticos en Brasil

Novedades

• EMA recommends approval of first denosumab biosimilar Jubbonti and Wyost
• First denosumab biosimilars approved in Canada and the US
• Dr Reddy's launches bevacizumab biosimilar Versavo in the UK
• EMA recommends approval of ustekinumab biosimilar Pyzchiva

Investigación

• Topline results for Polpharma Biologics’ vedolizumab biosimilar candidate
• Comparing biosimilar adoption: Medicare Advantage versus traditional Medicare
• Cuestionando la necesidad de evaluaciones de sensibilidad étnica para anticuerpos monoclonales biosimilares
• ANVISA's role in biosimilar medicine regulation and innovation promotion

General

• Addressing the persistent gap in Medicare access to Humira biosimilars
• Biosimilars of omalizumab
• Brasil avanza en el registro de biosimilares y se aproxima a Europa
• Insurer perspective on increasing biosimilar uptake in Canada

• Latin American Forum
• Fármacos complejos no biológicos
• Enfoque por país

• Directrices
• Políticas y legislación
• Informes

• Congresos
• Artículos patrocinados
• Enlaces patrocinados